- Preview Available
- Scholarly Journal
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings
Cancer Immunology, Immunotherapy; Heidelberg Vol. 60, Iss. 2, (Feb 2011): 261-271.
DOI:10.1007/s00262-010-0935-9
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.